Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial

NCT03242642 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.

NCT NCT03242642
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03242642 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Transcatheter Mitral Valve Replacement With the Medtronic Intrepid™ TMVR System in Patients With Severe Symptomatic Mitral Regurgitation - APOLLO Trial
Lead sponsor
Medtronic Cardiovascular
Phase
Not applicable
Overall status
Recruiting
Start date
October 23, 2017
Completion date
July 7, 2036
Enrollment
1,056 (estimated)
Sites
85

Conditions

As the registry lists them; a condition with its own page is linked.

mitral valve regurgitation